Mark Walters, MD
Professor
Pediatrics
School of Medicine

The over-arching goal of my research career has been to develop and expand curative therapies for hemoglobin disorders in particular and non-malignant hematopoietic disorders more broadly. I have focused on genome editing approaches most recently, which rely upon modification of autologous hematopoietic cells to elicit a curative effect.

Show full bio (50 words) Hide full bio

In collaboration with colleagues at UC Berkeley, BCHO and UCLA, we are pursuing genomic editing of the sickle mutation in hematopoietic stem cells using the CRSPR/Cas9 ribonucleoprotein system. I have a long track record of experience in cellular therapies for pediatric acquired and hereditary conditions and in bone marrow transplantation.

Education & Training

Show all (5) Hide

  • Diversity, Equity, and Inclusion Champion Training University of California 2019
  • Pediatric Hem/Onc/BMT fellowship Fred Hutch/Univ of Washington 06/1991
  • Pediatric Residency University of Washington 06/1988
  • M.D. Medicine University of California, San Diego 06/1985
  • A.B. Genetics University of California, Berkeley 06/1981

Websites

Show all (1) Hide

Grants and Projects

Show all (10) Hide

Publications (106)

Top publication keywords:
Bone Marrow TransplantationTransplantation ConditioningHematopoietic Stem Cell TransplantationTransplantation, HomologousUnrelated Donorsbeta-ThalassemiaGraft vs Host DiseaseAnemia, Sickle CellHistocompatibility TestingHemoglobinopathiesThalassemiaGenetic Therapybeta-GlobinsBone MarrowCord Blood Stem Cell Transplantation

Show all (101 more) Hide